| Net Cash Provided by (Used in) Operating Activities |
$1,012,000,000 |
USD |
1346% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$14,274,000,000 |
USD |
-22% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$16,888,000,000 |
USD |
-3.1% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
90,000,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
578,981,398 |
shares |
2.3% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$1,599,000,000 |
USD |
-179% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$20,591,000,000 |
USD |
20% |
Q4 2025 |
FY 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$321,000,000 |
USD |
92% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$251,000,000 |
USD |
235% |
Q4 2025 |
FY 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$6,341,000,000 |
USD |
36% |
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
28,749,665 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Unrecognized Tax Benefits |
$8,000,000 |
USD |
-20% |
Q4 2025 |
FY 2025 |
| Additional Paid in Capital |
$16,954,000,000 |
USD |
11% |
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Outstanding |
28,749,665 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Depreciation, Depletion and Amortization |
$308,000,000 |
USD |
29% |
Q1 2025 |
Q1 2025 |
| Share-based Payment Arrangement, Expense |
$789,000,000 |
USD |
9.4% |
Q4 2025 |
FY 2025 |